Y-mAbs Therapeutics, Inc. Increase (Decrease) in Inventories
Y-mAbs Therapeutics, Inc. reported Increase (Decrease) in Inventories of $4.49 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2024-11-08
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2024-09-30 was $1.06M, a 45.02% decline year-over-year.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2024-06-30 was $50.00K.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2024-03-31 was $3.38M, a 50.82% increase year-over-year.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2023-12-31 was -$2.05M, a 545.22% decline year-over-year.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for fiscal 2023 was -$1.64M, a 237.56% decline from fiscal 2022.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for fiscal 2022 was $1.19M, a 78.41% decline from fiscal 2021.
- Y-mAbs Therapeutics, Inc. increase (decrease) in inventories for fiscal 2021 was $5.51M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2024-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.11M derived: sum of 2 quarters · filed 2024-11-08 | $4.49M 10-Q · filed 2024-11-08 | $2.44M derived: sum of 4 quarters · filed 2024-11-08 |
| 2024-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.43M 10-Q · filed 2024-08-12 | $1.39M derived: sum of 3 quarters · filed 2024-08-12 | $3.31M derived: sum of 4 quarters · filed 2024-11-08 |
| 2024-03-31 | $3.38M 10-Q · filed 2024-05-07 | $1.33M derived: sum of 2 quarters · filed 2024-05-07 | $3.26M derived: sum of 3 quarters · filed 2024-11-08 | -$497.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$122.00K derived: sum of 2 quarters · filed 2024-11-08 | -$3.88M derived: sum of 3 quarters · filed 2024-11-08 | -$1.64M 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.83M derived: sum of 2 quarters · filed 2024-11-08 | $411.00K 10-Q · filed 2024-11-08 | $871.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.51M 10-Q · filed 2024-08-12 | -$1.05M derived: sum of 3 quarters · filed 2024-08-12 | -$1.61M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.24M 10-Q · filed 2024-05-07 | $2.70M derived: sum of 2 quarters · filed 2024-05-07 | $2.15M derived: sum of 3 quarters · filed 2024-05-07 | $3.36M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$92.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.11M derived: sum of 3 quarters · filed 2024-02-29 | $1.19M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $654.00K derived: sum of 2 quarters · filed 2023-11-13 | $730.00K 10-Q · filed 2023-11-13 | $1.46M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.28M 10-Q · filed 2023-08-10 | $2.01M derived: sum of 3 quarters · filed 2023-08-10 | $2.97M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $76.00K 10-Q · filed 2023-05-08 | $801.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.77M derived: sum of 3 quarters · filed 2023-05-08 | $4.58M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.69M derived: sum of 2 quarters · filed 2023-03-30 | $4.51M derived: sum of 3 quarters · filed 2023-03-30 | $5.51M 10-K · filed 2023-03-30 |
| 2021-09-30 | $967.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $3.78M derived: sum of 2 quarters · filed 2022-11-07 | $4.79M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.82M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-09 |